PBRM1’s new function supports a novel cancer-promoting mechanism
New findings suggest that cancer-associated defects in chromatin remodeler genes can drive cancer by disrupting cytoskeletal activities.
Read More
SETD2
Changing the perspective on the ‘Cinderella of the cytoskeleton’
Actin modifications, such as those described here, are increasingly being recognized as key regulators of cytoskeleton dynamics.
Read More
Chromosome remodeler SETD2 also remodels the cytoskeleton in kidney cancer cells
Kidney cancer begins when certain genes mutate and, as a result, alter how key molecules work. One of these key molecules is SETD2, which is
Read More